\-\ Texto\\:\\ \ \(0\)\
\-\ er\ \(88390\)\
\-\ lhermitte\\-duclos\ \(0\)\
\-\ who\\ grade\\ i\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ cerebellar\\ neurons\\ \\(hamartomatous\\?\\)\\ \ \(0\)\
\-\ synonyms\\:\\ ganglioneuroma\\,\\ purkinjioma\\,\\ granular\\ cell\\ hypertrophy\\ of\\ the\\ cerebellum\\,\\ gangliocytoma\\ dysplasticum\\,\\ \ \(0\)\
\-\ hamartoma\\ of\\ the\\ cerebellum\\ \ \(0\)\
\-\ common\\ locations\\:\\ cerebellar\\ hemispheres\\ \ \(0\)\
\-\ demographics\\:\\ early\\ adulthood\\ \ \(0\)\
\-\ clinical\\ presentation\\:\\ hydrocephalus\\;\\ may\\ also\\ be\\ found\\ as\\ an\\ incidental\\ lesion\\ \ \(0\)\
\-\ histology\\:\\ derangement\\ of\\ normal\\ laminar\\ cellular\\ organization\\ of\\ cerebellum\\:\\ 1\\)\\ thickening\\ of\\ outer\\ molecular\\ cell\\ \ \(0\)\
\-\ layer\\,\\ 2\\)\\ loss\\ of\\ middle\\ purkinje\\ cell\\ layer\\,\\ 3\\)\\ infiltration\\ of\\ inner\\ granular\\ cell\\ layer\\ with\\ dysplastic\\ ganglion\\ cells\\ \ \(0\)\
\-\ special\\ stains\\:\\ synaptophysin\\ positive\\ \ \(0\)\
\-\ progression\\:\\ good\\ prognosis\\ with\\ surgical\\ excision\\.\\ recurrence\\ rare\\.\\ \ \(0\)\
\-\ radiology\\:\\ non\\-enhancing\\ cerebellar\\ hemisphere\\ mass\\ with\\ characteristic\\ striated\\ mr\\ appearance\\.\\ occasionally\\ \ \(0\)\
\-\ contains\\ calcifications\\.\\ \ \(1\)\
\-\ comments\\:\\ associated\\ with\\ cowden\\'s\\ disease\\ \\(autosomal\\ dominant\\,\\ mucosal\\ neuromas\\ and\\ breast\\ cancer\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ layer\\:\\ 0\\.30518589964703896\ \(0\)\
\-\ cell\\:\\ 0\\.26138607080080345\ \(0\)\
\-\ cerebellum\\:\\ 0\\.25188712202028046\ \(0\)\
\-\ cerebellar\\:\\ 0\\.2243584056644737\ \(0\)\
\-\ granular\\:\\ 0\\.22016006971880878\ \(0\)\
\-\ purkinjioma\\:\\ 0\\.1461467008514954\ \(0\)\
\-\ dysplasticum\\:\\ 0\\.1461467008514954\ \(0\)\
\-\ of\\:\\ 0\\.143071265252842\ \(0\)\
\-\ purkinje\\:\\ 0\\.13965097487113334\ \(0\)\
\-\ synaptophysin\\:\\ 0\\.13965097487113334\ \(0\)\
\-\ organization\\:\\ 0\\.13146732796939742\ \(0\)\
\-\ neuromas\\:\\ 0\\.13146732796939742\ \(0\)\
\-\ derangement\\:\\ 0\\.1285464579621794\ \(0\)\
\-\ synonyms\\:\\ 0\\.12607689755902562\ \(0\)\
\-\ comments\\:\\ 0\\.12607689755902562\ \(0\)\
\-\ neurons\\:\\ 0\\.12393766703358754\ \(0\)\
\-\ hamartomatous\\:\\ 0\\.12205073198181735\ \(0\)\
\-\ gangliocytoma\\:\\ 0\\.1203628110604435\ \(0\)\
\-\ cowden\\:\\ 0\\.1203628110604435\ \(0\)\
\-\ laminar\\:\\ 0\\.11615962233978684\ \(0\)\
\-\ molecular\\:\\ 0\\.11497238065007168\ \(0\)\
\-\ striated\\:\\ 0\\.11497238065007168\ \(0\)\
\-\ demographics\\:\\ 0\\.11386708508008143\ \(0\)\
\-\ ganglioneuroma\\:\\ 0\\.10925829415148955\ \(0\)\
\-\ stains\\:\\ 0\\.10847665466970963\ \(0\)\
\-\ adulthood\\:\\ 0\\.1070192475307135\ \(0\)\
\-\ cellular\\:\\ 0\\.10568343817834551\ \(0\)\
\-\ special\\:\\ 0\\.10445048909250136\ \(0\)\
\-\ ganglion\\:\\ 0\\.1027625681711275\ \(0\)\
\-\ dysplastic\\:\\ 0\\.10172863321567965\ \(0\)\
\-\ histology\\:\\ 0\\.09699516903939912\ \(0\)\
\-\ locations\\:\\ 0\\.09557019193470799\ \(0\)\
\-\ autosomal\\:\\ 0\\.09426167463574806\ \(0\)\
\-\ infiltration\\:\\ 0\\.09013114105765166\ \(0\)\
\-\ hamartoma\\:\\ 0\\.08989022777378831\ \(0\)\
\-\ inner\\:\\ 0\\.0894190046413975\ \(0\)\
\-\ contains\\:\\ 0\\.08896124688611884\ \(0\)\
\-\ hemispheres\\:\\ 0\\.08873718125495555\ \(0\)\
\-\ outer\\:\\ 0\\.08787100104149653\ \(0\)\
\-\ occasionally\\:\\ 0\\.08766158065449786\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.08607802773401213\ \(0\)\
\-\ mucosal\\:\\ 0\\.08607802773401213\ \(0\)\
\-\ hemisphere\\:\\ 0\\.08552235012905977\ \(0\)\
\-\ dominant\\:\\ 0\\.08552235012905977\ \(0\)\
\-\ progression\\:\\ 0\\.08379806044864796\ \(0\)\
\-\ prognosis\\:\\ 0\\.08042058395139384\ \(0\)\
\-\ origin\\:\\ 0\\.07866659930144945\ \(0\)\
\-\ recurrence\\:\\ 0\\.0754517681755537\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.07460092585840841\ \(0\)\
\-\ good\\:\\ 0\\.07432706566015443\ \(0\)\
\-\ characteristic\\:\\ 0\\.07388078522940918\ \(0\)\
\-\ radiology\\:\\ 0\\.07319162815939856\ \(0\)\
\-\ excision\\:\\ 0\\.07205264081784019\ \(0\)\
\-\ with\\:\\ 0\\.0715783751498693\ \(0\)\
\-\ cells\\:\\ 0\\.07041190824126405\ \(0\)\
\-\ rare\\:\\ 0\\.0689884394387419\ \(0\)\
\-\ er\\:\\ 0\\.06835262458718919\ \(0\)\
\-\ incidental\\:\\ 0\\.06774108348908871\ \(0\)\
\-\ calcifications\\:\\ 0\\.0666959021790365\ \(0\)\
\-\ breast\\:\\ 0\\.06636213111744416\ \(0\)\
\-\ early\\:\\ 0\\.06587416147112164\ \(0\)\
\-\ grade\\:\\ 0\\.06571475287752478\ \(0\)\
\-\ middle\\:\\ 0\\.06534885436147524\ \(0\)\
\-\ presentation\\:\\ 0\\.06290885195835946\ \(0\)\
\-\ thickening\\:\\ 0\\.0621716519821237\ \(0\)\
\-\ cancer\\:\\ 0\\.06086978423456193\ \(0\)\
\-\ positive\\:\\ 0\\.060218924511494104\ \(0\)\
\-\ found\\:\\ 0\\.059131147184338574\ \(0\)\
\-\ mr\\:\\ 0\\.059131147184338574\ \(0\)\
\-\ clinical\\:\\ 0\\.05791638542129306\ \(0\)\
\-\ loss\\:\\ 0\\.05567592600176164\ \(0\)\
\-\ appearance\\:\\ 0\\.05509330065037803\ \(0\)\
\-\ common\\:\\ 0\\.051826539393190166\ \(0\)\
\-\ who\\:\\ 0\\.05169377262661952\ \(0\)\
\-\ associated\\:\\ 0\\.04816747014049177\ \(0\)\
\-\ may\\:\\ 0\\.04598850309660117\ \(0\)\
\-\ surgical\\:\\ 0\\.04441675695173917\ \(0\)\
\-\ lesion\\:\\ 0\\.04381265883079678\ \(0\)\
\-\ also\\:\\ 0\\.042985529481231396\ \(0\)\
\-\ disease\\:\\ 0\\.038360751692240895\ \(0\)\
\-\ normal\\:\\ 0\\.037312442189865444\ \(0\)\
\-\ be\\:\\ 0\\.03707179696981155\ \(0\)\
\-\ as\\:\\ 0\\.036713148254066574\ \(0\)\
\-\ the\\:\\ 0\\.03646978442733453\ \(0\)\
\-\ an\\:\\ 0\\.03494584121227237\ \(0\)\
\-\ mass\\:\\ 0\\.03490715384385543\ \(0\)\
\-\ and\\:\\ 0\\.01888387456660421\ \(0\)\
